ACKR3 is constitutively expressed and is upregulated throughout the CNS during demyelination in several nonclinical models of MS, especially in meningeal and parenchymal blood vessels, on astrocytes, and on Olig2-expressing oligodendrocyte precursor cells (OPCs) [7–9]. The gene discussed is ACKR3; the disease is myeloid sarcoma.